Patients experience significant improvements in health-related quality of life measures after receiving a lung transplantation, but there is no significant difference in improvements in health-related quality of life measures regarding patient age, according to study results.
“We found that recipient age has a minimal effect on the [health-related quality of life (HRQL)] benefits of transplantation, and that age accounts for very little of the variability in quality-adjusted survival after transplant,” authors wrote.
The researchers stressed there should be no age nor diagnosis discrimination in lung transplants.
“Our data suggest that age and diagnosis should not be used to discriminate between potential lung transplant recipients, if improvement in HRQL is a desired goal of transplantation,” the researchers wrote. “However, a relatively high mortality rate still undermines the overall success of lung transplantation. It is hoped that future advances in the care of lung transplant patients will yield even more impressive benefits.”
Age, Diagnosis Should Not Be Factors in Determining Lung Transplant Recipients
